Cefepime Injection, Powder, For Solution
Product Images NDC 25021-121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefepime (NDC 25021-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Cef0e 0012 01)

FDA Label Image

Structural Formula (Cef0e 0012 02)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cef0e 0012 03)

Package Label – Principal Display Panel – Vial Label (Cef0e 0012 03)
Description: The text provides details about a pharmaceutical product manufactured by Sagent Pharmaceuticals in Brazil. It includes information about the product code "R06784 / ABL4764R01" and mentions the location in Schaumburg, Illinois, USA. The product is identified as Cefepime, a medication available in 1-gram vials for injection, designated with a specific product number. The text also contains some procedural information and copyright details from the manufacturer for the year 2020.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cef0e 0012 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.